Tschoep-Lechner, Katharina <br/><br/>
Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment.  [electronic resource] 

 -  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group  2012 
 - 33-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-5157 
<br/><br/><label>Standard No.: </label>10.3109/02656736.2011.626834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigen Presentation<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival<br/>Green Fluorescent Proteins--immunology<br/>Hot Temperature<br/>Humans<br/>Ifosfamide--pharmacology<br/>Interferon-gamma--immunology<br/>Monophenol Monooxygenase--genetics<br/>Sarcoma--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transduction, Genetic<br/>Tumor Cells, Cultured<br/>Vaccinia--immunology<br/>Vaccinia virus--genetics